U.S. FDA approves Takeda's lung cancer drug as second-line treatment

(Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Friday that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the company acquired the drug's developer, Ariad Pharmaceuticals Inc.

Mexican Congress approves use of medical marijuana

MEXICO CITY (Reuters) - Mexico's Lower House of Congress passed a bill on Friday to legalize the use of marijuana and cannabis for medical and scientific needs, a step closer to outright legalization in a country long scarred by warring drug cartels.

Is active surveillance safe for men with family history of prostate cancer?

(Reuters Health) - Having a family history of prostate cancer doesn’t make it more risky for men with a new diagnosis of the disease to initially hold off on active treatment in favor of monitoring with periodic lab tests, a research review suggests.